SIGHT SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.55 USD | +1.83% |
|
0.00% | +7.56% |
Presentation Operator MessageOperator (Operator)Hello and welcome to Sight Sciences' Fourth Qu...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
Calendar
06/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5.55
USD
Average target price
6.1
USD
Spread / Average Target
+9.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.56% | 271M | |
| -4.98% | 181B | |
| +2.84% | 112B | |
| -2.68% | 67.92B | |
| +4.53% | 50.1B | |
| +8.00% | 44.27B | |
| +9.65% | 40.41B | |
| +25.30% | 31.95B | |
| -0.17% | 25.82B | |
| +21.57% | 25.29B |
- Stock Market
- Equities
- SGHT Stock
- News Sight Sciences, Inc.
- Transcript : Sight Sciences, Inc., Q4 2022 Earnings Call, Mar 13, 2023
